Coral Laboratories Share Price
CORALAB
Live Coral Laboratories Share Price Chart
Coral Laboratories Performance
Days Range
| Previous Close | ₹568.45 |
|---|---|
| Open | ₹586 |
| Volume | 1,093 |
| Day's Range | ₹556.00 - ₹586.00 |
|---|---|
| 52W Range | ₹360.00 - ₹659.00 |
| Market Cap | ₹205.15 Cr |
Coral Laboratories Fundamentals
| ROCE(TTM) | 10.89 |
|---|---|
| P/E Ratio (TTM) | 12.52 |
| P/B Ratio | 0.98 |
| Industry P/E | 50.65 |
| Debt to Equity | 0.02 |
| ROE | 7.83 |
| EPS (TTM) | 45.27 |
| Dividend Yield | 0.35 |
| Book Value | 585.74 |
| Face Value | 10 |
| ROCE(TTM) | 10.89 |
|---|---|
| P/E Ratio (TTM) | 12.52 |
| P/B Ratio | 0.98 |
| Industry P/E | 50.65 |
| Debt to Equity | 0.02 |
| ROE | 7.83 |
|---|---|
| EPS (TTM) | 45.27 |
| Dividend Yield | 0.35 |
| Book Value | 585.74 |
| Face Value | 10 |
Coral Laboratories Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 19.03 | 21.56 | 26.48 | 29.62 |
| Expenses | 14.55 | 20.36 | 20.82 | 24.80 |
| Profit before tax | 7.42 | 3.70 | 8.29 | 6.94 |
| Operating Profit | 5.82 | 2.78 | 5.22 | 5.39 |
| Net Profit | 5.82 | 2.78 | 5.22 | 5.39 |
| EPS in Rs | 15.39 | 7.77 | 14.65 | 15.08 |
Coral Laboratories Shareholding Pattern
Promoters
71.51%
Retail And Others
28.49%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Coral Laboratories
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations.
To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully
CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated.
During the year 1999-2000, the company has received ISO-9002 Certification.
Parent Organisation
Coral
Managing Director
NA
Founded
1981
NSE Symbol
Top Mutual Funds Invested in Coral Laboratories Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,930.0 -2.00 (-0.10%) | ₹4,61,847.99 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,477.0 -23.00 (-0.27%) | ₹2,25,648.29 | 5,636.5 - 8,674.0 |
| Torrent Pharmaceuticals Ltd | 4,833.0 -81.50 (-1.66%) | ₹1,84,109.45 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,450.0 -8.80 (-0.60%) | ₹1,17,138.71 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,135.2 -32.10 (-2.75%) | ₹1,13,715.44 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,235.0 -15.30 (-0.68%) | ₹1,02,191.47 | 1,875.0 - 2,529.5 |
Popular Stocks
Coral Laboratories Ltd FAQs
Can I buy Coral Laboratories Ltd (Coral Laboratories Ltd) from Angel One?
Yes, You can buy Coral Laboratories Ltd (Coral Laboratories Ltd) shares by opening a Demat account with Angel One.
How do I buy Coral Laboratories Ltd (Coral Laboratories Ltd) from Angel One?
Coral Laboratories Ltd (Coral Laboratories Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Coral Laboratories Ltd (Coral Laboratories Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Coral Laboratories Ltd (Coral Laboratories Ltd) shares.
1. Direct investment: You can buy Coral Laboratories Ltd (Coral Laboratories Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Coral Laboratories Ltd (Coral Laboratories Ltd) shares.
